Pages that link to "Item:Q2194989"

The following pages link to Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations (Q2194989):

Displaying 50 items.

• A modified numerical method for bifurcations of fixed points of ODE systems with periodically pulsed inputs (Q273321) (← links)
• Analysis of the dynamics of a tumor-immune system with chemotherapy and immunotherapy and quadratic optimal control (Q286487) (← links)
• Stability and bifurcation analysis of delay induced tumor immune interaction model (Q298527) (← links)
• Activation of effector immune cells promotes tumor stochastic extinction: a homotopy analysis approach (Q298756) (← links)
• Mathematical model of tumor-immune surveillance (Q307632) (← links)
• A mathematical prognosis model for pancreatic cancer patients receiving immunotherapy (Q309128) (← links)
• Mathematical and numerical analysis of a mathematical model of mixed immunotherapy and chemotherapy of cancer (Q316874) (← links)
• Dynamical analysis of chemotherapy models with time-dependent infusion (Q332394) (← links)
• Mathematical modelling and analysis of the tumor treatment regimens with pulsed immunotherapy and chemotherapy (Q332917) (← links)
• Modelling lymphoma therapy and outcome (Q458674) (← links)
• A validated mathematical model of tumor growth including tumor-host interaction, cell-mediated immune response and chemotherapy (Q486657) (← links)
• Cost-effectiveness analysis of optimal strategy for tumor treatment (Q508264) (← links)
• Dynamic analysis of an antitumor model and investigation of the therapeutic effects for different treatment regimens (Q520304) (← links)
• Optimal control for selected cancer chemotherapy ODE models: a view on the potential of optimal schedules and choice of objective function (Q630983) (← links)
• On the modelling of genetic mutations and immune system competition (Q639041) (← links)
• Diffusive tumor-immune interaction systems under immunotherapy (Q660705) (← links)
• A structural methodology for modeling immune-tumor interactions including pro- and anti-tumor factors for clinical applications (Q669039) (← links)
• Cancer immunoediting: a process driven by metabolic competition as a predator-prey-shared resource type model (Q739245) (← links)
• A cancer model for the angiogenic switch (Q739655) (← links)
• On probabilistic certification of combined cancer therapies using strongly uncertain models (Q739722) (← links)
• Study of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancer (Q827694) (← links)
• Model for acid-mediated tumour invasion with chemotherapy intervention. II: Spatially heterogeneous populations (Q899329) (← links)
• Parameter identification problems and analysis of the impact of porous media in biofluid heat transfer in biological tissues during thermal therapy (Q974543) (← links)
• A two-compartment model interacting with dynamic drugs (Q1033071) (← links)
• Two-compartment model interacting with proliferating regulatory factor (Q1049244) (← links)
• Phase transitions in tumor growth. III: Vascular and metastasis behavior (Q1619897) (← links)
• Mixed immunotherapy and chemotherapy of tumors: feedback design and model updating schemes (Q1623948) (← links)
• On immunotherapies and cancer vaccination protocols: a mathematical modelling approach (Q1624565) (← links)
• Combination therapies and intra-tumoral competition: insights from mathematical modeling (Q1642492) (← links)
• Ordinary differential equation models for adoptive immunotherapy (Q1648966) (← links)
• Modeling cancer immunotherapy: assessing the effects of lymphocytes on cancer cell growth and motility (Q1672944) (← links)
• State-dependent impulsive control strategies for a tumor-immune model (Q1677700) (← links)
• An extended mathematical model of tumor growth and its interaction with the immune system, to be used for developing an optimized immunotherapy treatment protocol (Q1680709) (← links)
• The dose-dense principle in chemotherapy (Q1705272) (← links)
• Mathematical model of chimeric anti-gene receptor (CAR) T cell therapy with presence of cytokine (Q1713207) (← links)
• Modeling anti-tumor Th1 and Th2 immunity in the rejection of melanoma (Q1720105) (← links)
• Bounding the dynamics of a chaotic-cancer mathematical model (Q1721728) (← links)
• Bridging blood cancers and inflammation: the reduced cancitis model (Q1721804) (← links)
• Dynamical behaviour of a tumor-immune system with chemotherapy and optimal control (Q1728939) (← links)
• The combined effects of optimal control in cancer remission (Q1732198) (← links)
• Stability analysis of a chemotherapy model with delays (Q1733185) (← links)
• A mathematical model of tumor-immune interactions (Q1787000) (← links)
• Simulation of tumor response to immunotherapy using a hybrid cellular automata model (Q1788276) (← links)
• Optimization of combination therapy for chronic myeloid leukemia with dosing constraints (Q1789085) (← links)
• A mathematical model of cell-mediated immune response to tumor (Q1980070) (← links)
• Stability and Hopf bifurcations in a competitive tumour-immune system with intrinsic recruitment delay and chemotherapy (Q1981174) (← links)
• Tumor clearance analysis on a cancer chemo-immunotherapy mathematical model (Q2008266) (← links)
• Optimal control of tumour-immune model with time-delay and immuno-chemotherapy (Q2010733) (← links)
• Spatial avascular growth of tumor in a homogeneous environment (Q2013437) (← links)
• Combined therapy for treating solid tumors with chemotherapy and angiogenic inhibitors (Q2033852) (← links)